pr newswire

0
CVS Caremark Data Illustrates How Clinical Pharmacist Interventions can
PR Newswire (press release)
“Enabling members with diabetes to achieve optimal management of their underlying disease, as well as other related conditions such as high blood pressure,

and more »

Filed under News and Info by on . Comment#

0
CVS Caremark Data Illustrates How Clinical Pharmacist Interventions can
PR Newswire (press release)
“Enabling members with diabetes to achieve optimal management of their underlying disease, as well as other related conditions such as high blood pressure,

and more »

Filed under News and Info by on . Comment#

0

HULIQ
Diagnosing Diabetes No Longer Requires Fasting
HULIQ
The AACE evaluated the use A1c for type 2 diabetes, which is less troublesome to patients who are otherwise forced to fast and undergo hours of glucose
American Association of Clinical Endocrinologists Approves New Diagnosis for PR Newswire (press release)

all 7 news articles »

Filed under News and Info by on . Comment#

0
Reportlinker Adds The Future of the Diabetes Care Devices Market to 2016 – The
IT News Online
27 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: The Future of the Diabetes Care Devices
The Future of the Diabetes Care Devices Market to 2016 – The Key Demand Boosh Plr (press release) (blog)
Reportlinker Adds The Future of the Diabetes Care Devices Market to 2016 – The PR Newswire (press release)

all 19 news articles »

Filed under News and Info by on . Comment#

0

TopNews United States
Liraglutide approved for type 2 diabetes
TheHeart.Org
Liraglutide is the first once-daily human glucagonlike peptide-1 (GLP-1) analog indicated for the treatment of type 2 diabetes.
Approved Diabetes Treatment Victoza Sparks Battle for Profits HULIQ
Novo Nordisk’s Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes PR Newswire (press release)

all 224 news articles »

Filed under News and Info by on . Comment#

0
Intrinsic Licenses Two Type 2 Diabetes Markers to Ortho-Clinical Diagnostics
Genetic Engineering News (press release)
Ortho-Clinical Diagnostics negotiated an exclusive license to two diabetes biomarkers discovered recently by Intrinsic Bioprobes.
Ortho-Clinical Diagnostics Licenses Intrinsic Bioprobes’ Markers GenomeWeb Daily News
Intrinsic Bioprobes Announces the Discovery and Exclusive Licensing of Novel PR Newswire (press release)

all 10 news articles »

Filed under News and Info by on . Comment#

0
Lexicon Pharma Gains On Study Results For Diabetes Treatment
Wall Street Journal
The four-week Phase II study was conducted on 36 patients with type 2 diabetes. Patients taking LX4211 showed a statistically significant decrease in
Market Report — In Play (LXRX) MSN Money
Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in PR Newswire (press release)
LXRX – Lexicon Pharma (NASDAQ) $2.63 – $453M (MarketCap) World Market Media (blog)
RTT News
all 38 news articles »

Filed under News and Info by on . Comment#

Filed under News and Info by on . Comment#

0
Cancer, Heart Disease, Stroke, Diabetes, Chronic Pain and Depression Share a
PR Newswire (press release)
hypertension, autoimmune diseases, diabetes, depression, chronic pain, osteoarthritis, osteoporosis, muscle weakness, muscle wasting, birth defects,

and more »

Filed under News and Info by on . Comment#

0
Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health
PR Newswire (press release)
13 /PRNewswire/ — A new analysis found that the cost of diabetes and pre-diabetes reached $218 billion in 2007, with the exploding number of cases of type

and more »

Filed under News and Info by on . Comment#

SEO Powered by Platinum SEO from Techblissonline